Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the baby.

There are several risk factors that increase the likelihood of shoulder dystocia, including fetal macrosomia (large baby), high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior medical assistance immediately. The McRoberts’ maneuver is often used to help deliver the baby. This involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant harm to the mother. Oxytocin administration is not effective in treating shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury or neonatal death for the baby. It is important to manage shoulder dystocia promptly and effectively to minimize these risks.

The ectocervix is typically covered by stratified squamous non-keratinized epithelium. If a patient presents with the described symptoms, it is important to investigate further for potential cervical cancer or cervical polyps, which can be discovered during routine gynaecological examinations. Pseudostratified columnar epithelium is not found in the cervix, while simple columnar epithelium is typically found in the endocervix. Simple squamous non-keratinized epithelium is not present in the ectocervix, which has multiple layers of squamous epithelium.

Anatomy of the Uterus

The uterus is a female reproductive organ that is located within the pelvis and is covered by the peritoneum. It is supplied with blood by the uterine artery, which runs alongside the uterus and anastomoses with the ovarian artery. The uterus is supported by various ligaments, including the central perineal tendon, lateral cervical, round, and uterosacral ligaments. The ureter is located close to the uterus, and injuries to the ureter can occur when there is pathology in the area.

The uterus is typically anteverted and anteflexed in most women. Its topography can be visualized through imaging techniques such as ultrasound or MRI. Understanding the anatomy of the uterus is important for diagnosing and treating various gynecological conditions.

Macrosomia is a significant risk factor for neonatal brachial plexus injuries resulting from shoulder dystocia. Maternal diabetes mellitus, not diabetes insipidus, is the leading cause of macrosomia, which is often associated with a high BMI. While polyhydramnios may result from foetal insulin resistance due to maternal diabetes mellitus, it is not a specific risk factor for brachial plexus injuries as there are many other causes of polyhydramnios. A family history of preeclampsia is not relevant to this condition.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the baby.

There are several risk factors that increase the likelihood of shoulder dystocia, including fetal macrosomia (large baby), high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior medical assistance immediately. The McRoberts’ maneuver is often used to help deliver the baby. This involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant harm to the mother. Oxytocin administration is not effective in treating shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury or neonatal death for the baby. It is important to manage shoulder dystocia promptly and effectively to minimize these risks.

During pregnancy, progesterone plays a crucial role in causing various changes in the body, including the relaxation of smooth muscles, which leads to a decrease in blood pressure. On the other hand, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) stimulate the release of estrogen and testosterone, which are essential for the menstrual cycle and pregnancy, but do not directly cause any significant changes.

While raised levels of estrogen in the first trimester may cause nausea and other symptoms like spider naevi, palmar erythema, and skin pigmentation, they are not responsible for pregnancy-related cardiovascular changes. Similarly, testosterone typically causes symptoms of hyperandrogenism, such as hirsutism and acne, which are not related to pregnancy but are seen in conditions like polycystic ovary syndrome.

During pregnancy, various physiological changes occur in the body, such as an increase in uterine size, cervical ectropion, increased vaginal discharge, and cardiovascular/haemodynamic changes like increased plasma volume, white cell count, platelets, ESR, cholesterol, and fibrinogen, and decreased albumin, urea, and creatinine. Progesterone-related effects, such as muscle relaxation, can cause decreased blood pressure, constipation, ureteral dilation, bladder relaxation, biliary stasis, and increased tidal volume.

Oestrogen and Progesterone: Their Sources and Functions

Oestrogen and progesterone are two important hormones in the female body. Oestrogen is primarily produced by the ovaries, but can also be produced by the placenta and blood via aromatase. Its functions include promoting the development of genitalia, causing the LH surge, and increasing hepatic synthesis of transport proteins. It also upregulates oestrogen, progesterone, and LH receptors, and is responsible for female fat distribution. On the other hand, progesterone is produced by the corpus luteum, placenta, and adrenal cortex. Its main function is to maintain the endometrium and pregnancy, as well as to thicken cervical mucous and decrease myometrial excitability. It also increases body temperature and is responsible for spiral artery development.

It is important to note that these hormones work together in regulating the menstrual cycle and preparing the body for pregnancy. Oestrogen promotes the proliferation of the endometrium, while progesterone maintains it. Without these hormones, the menstrual cycle and pregnancy would not be possible. Understanding the sources and functions of oestrogen and progesterone is crucial in diagnosing and treating hormonal imbalances and reproductive disorders.

The patient is exhibiting signs of HELLP syndrome, which is a complication during pregnancy that involves haemolysis, elevated liver enzymes, and low platelets. This condition often occurs alongside pregnancy-induced hypertension or pre-eclampsia. Although the patient is also displaying symptoms of pre-eclampsia such as headache, shoulder tip pain, and nausea, the presence of jaundice indicates that it is HELLP syndrome rather than pre-eclampsia. Pre-eclampsia is a pregnancy disorder that typically involves high blood pressure and damage to another organ system, usually the kidneys in the form of proteinuria. It usually develops after 20 weeks of pregnancy in women who previously had normal blood pressure.

Jaundice During Pregnancy

During pregnancy, jaundice can occur due to various reasons. One of the most common liver diseases during pregnancy is intrahepatic cholestasis of pregnancy, which affects around 1% of pregnancies and is usually seen in the third trimester. Symptoms include itching, especially in the palms and soles, and raised bilirubin levels. Ursodeoxycholic acid is used for symptomatic relief, and women are typically induced at 37 weeks. However, this condition can increase the risk of stillbirth.

Acute fatty liver of pregnancy is a rare complication that can occur in the third trimester or immediately after delivery. Symptoms include abdominal pain, nausea, vomiting, headache, jaundice, and hypoglycemia. ALT levels are typically elevated. Supportive care is the initial management, and delivery is the definitive management once the patient is stabilized.

Gilbert’s and Dubin-Johnson syndrome may also be exacerbated during pregnancy. Additionally, HELLP syndrome, which stands for Haemolysis, Elevated Liver enzymes, Low Platelets, can also cause jaundice during pregnancy. It is important to monitor liver function tests and seek medical attention if any symptoms of jaundice occur during pregnancy.

Bacterial Vaginosis and Other Causes of Vaginal Discharge

Vaginal discharge is a common concern among women, and bacterial vaginosis (BV) is the most common non-STI-related cause. BV occurs when there is an imbalance in the normal flora of the vaginal mucosa, which is mostly made up of Lactobacilli. These bacteria produce hydrogen peroxide, which helps to maintain a healthy pH level in the vagina by killing off anaerobes. However, disruptions to the normal flora, such as the use of new products or hormonal imbalances, can lead to the death of Lactobacilli and an increase in pH. This creates an environment where anaerobes like Gardnerella vaginalis can thrive and cause BV.

Candidiasis, caused by the fungus Candida albicans, is the second most common cause of non-STI-related vaginal discharge. It is characterized by thick white curds attached to the vaginal mucosa and is often associated with vulval itching. However, this patient does not describe these symptoms.

It is important to note that sexually transmitted infections like chlamydia, gonorrhoeae, and trichomoniasis can also cause vaginal discharge. However, there is no indication in this patient’s clinical history that she may be affected by any of these infections. the causes of vaginal discharge can help women identify when they need to seek medical attention and receive appropriate treatment.

Polycystic ovary syndrome leads to anovulation with normal levels of FSH and estrogen, known as normogonadotropic normoestrogenic anovulation. LH levels may be elevated or normal in this condition.

Hypogonadotropic hypogonadal anovulation is caused by hypopituitarism or hyperprolactinemia, resulting in low levels of gonadotropins and estrogen. However, hyperprolactinemia can be ruled out based on gonadotropin and estrogen levels alone.

Hypothalamic amenorrhea is a functional cause of hypogonadotropic hypogonadal anovulation, often due to factors such as low BMI, stress, or excessive exercise.

Understanding Ovulation Induction and Its Categories

Ovulation induction is a common treatment for couples who have difficulty conceiving naturally due to ovulation disorders. The process of ovulation requires a balance of hormones and feedback loops between the hypothalamus, pituitary gland, and ovaries. Anovulation can occur due to alterations in this balance, which can be classified into three categories: hypogonadotropic hypogonadal anovulation, normogonadotropic normoestrogenic anovulation, and hypergonadotropic hypoestrogenic anovulation. The goal of ovulation induction is to induce mono-follicular development and subsequent ovulation, leading to a singleton pregnancy.

There are various forms of ovulation induction, starting with the least invasive and simplest management option first. Exercise and weight loss are typically the first-line treatment for patients with polycystic ovarian syndrome, as ovulation can spontaneously return with even a modest 5% weight loss. Letrozole is now considered the first-line medical therapy for patients with PCOS due to its reduced risk of adverse effects on endometrial and cervical mucous compared to clomiphene citrate. Clomiphene citrate is a selective estrogen receptor modulator that acts primarily at the hypothalamus, blocking the negative feedback effect of estrogens. Gonadotropin therapy tends to be the treatment used mostly for women with hypogonadotropic hypogonadism.

One potential side effect of ovulation induction is ovarian hyperstimulation syndrome (OHSS), which can be life-threatening if not identified and managed promptly. OHSS occurs when ovarian enlargement with multiple cystic spaces form, and an increase in the permeability of capillaries leads to a fluid shift from the intravascular to the extra-vascular space. The severity of OHSS varies, with the risk of severe OHSS occurring in less than 1% of all women undergoing ovarian induction. Management includes fluid and electrolyte replacement, anticoagulation therapy, abdominal ascitic paracentesis, and pregnancy termination to prevent further hormonal imbalances.

Dairy products are a source of calcium, which is necessary for the mineralisation of teeth and bones. Zinc, an essential trace element found in animal-based foods, is involved in various biological processes such as gene expression and signal transduction. Magnesium is crucial for enzymes that synthesise or use ATP and interacts significantly with phosphate. Vitamin C acts as a reducing agent, and a lack of it can lead to scurvy.

Folic Acid: Importance, Deficiency, and Prevention

Folic acid is a vital nutrient that is converted to tetrahydrofolate (THF) in the body. THF plays a crucial role in transferring 1-carbon units to essential substrates involved in DNA and RNA synthesis. Green, leafy vegetables are a good source of folic acid. However, certain medications like phenytoin and methotrexate, pregnancy, and alcohol excess can cause folic acid deficiency. This deficiency can lead to macrocytic, megaloblastic anemia and neural tube defects.

To prevent neural tube defects during pregnancy, all women should take 400mcg of folic acid until the 12th week of pregnancy. Women at higher risk of conceiving a child with a neural tube defect should take 5 mg of folic acid from before conception until the 12th week of pregnancy. Women are considered higher risk if either partner has a neural tube defect, they have had a previous pregnancy affected by a neural tube defect, or they have a family history of a neural tube defect. Additionally, women with antiepileptic drugs or coeliac disease, diabetes, or thalassaemia trait, and those who are obese (BMI of 30 kg/m2 or more) are also at higher risk and should take the higher dose of folic acid.

If a cervical smear sample tests positive for hrHPV, it should be examined cytologically to check for any abnormal nuclear changes in the cells. Referral to colposcopy would only be necessary if the cytological examination shows abnormal results. Patients who test negative for hrHPV should return to routine screening. If the initial sample is inadequate, it should be repeated in three months. However, if there are three inadequate smears, the patient should be referred to colposcopy. If the cytology is normal despite being positive for hrHPV, the sample should be repeated in 12 months.

Understanding Cervical Cancer Screening Results

The cervical cancer screening program has evolved significantly in recent years, with the introduction of HPV testing allowing for further risk stratification. The NHS now uses an HPV first system, where a sample is tested for high-risk strains of human papillomavirus (hrHPV) first, and cytological examination is only performed if this is positive.

If the hrHPV test is negative, individuals can return to normal recall, unless they fall under the test of cure pathway, untreated CIN1 pathway, or require follow-up for incompletely excised cervical glandular intraepithelial neoplasia (CGIN) / stratified mucin producing intraepithelial lesion (SMILE) or cervical cancer. If the hrHPV test is positive, samples are examined cytologically, and if the cytology is abnormal, individuals will require colposcopy.

If the cytology is normal but the hrHPV test is positive, the test is repeated at 12 months. If the repeat test is still hrHPV positive and cytology is normal, a further repeat test is done 12 months later. If the hrHPV test is negative at 24 months, individuals can return to normal recall, but if it is still positive, they will require colposcopy. If the sample is inadequate, it will need to be repeated within 3 months, and if two consecutive samples are inadequate, colposcopy will be required.

For individuals who have previously had CIN, they should be invited for a test of cure repeat cervical sample in the community 6 months after treatment. The most common treatment for cervical intraepithelial neoplasia is large loop excision of transformation zone (LLETZ), which may be done during the initial colposcopy visit or at a later date depending on the individual clinic. Cryotherapy is an alternative technique.

When a fetus is in transverse lie, it means that its longitudinal axis is perpendicular to the long axis of the uterus. If an ECV has been attempted to change this position and has been unsuccessful, it is advisable to schedule an elective Caesarean section. This is because attempting a natural delivery would be pointless as the baby cannot fit through the pelvis in this position, which could result in a cord prolapse, hypoxia, and ultimately, death.

Transverse lie is an abnormal foetal presentation where the foetal longitudinal axis is perpendicular to the long axis of the uterus. It occurs in less than 0.3% of foetuses at term and is more common in women who have had previous pregnancies, have fibroids or other pelvic tumours, are pregnant with twins or triplets, have prematurity, polyhydramnios, or foetal abnormalities. Diagnosis is made during routine antenatal appointments through abdominal examination and ultrasound scan. Complications include pre-term rupture membranes and cord-prolapse. Management options include active management through external cephalic version or elective caesarian section. The decision to perform caesarian section over ECV will depend on various factors.

PPH, which is the loss of 500 millilitres or more of blood within 24 hours of delivery, is primarily caused by uterine atony. This occurs when the uterus fails to contract after the placenta is delivered. However, other potential causes must be ruled out through thorough clinical examination. To remember the causes of PPH, the acronym ‘the 4 Ts’ can be used: Tone (uterine atony), Tissue (retained products of conception), Trauma (to the genital tract or perineum), and Thrombin (coagulation abnormalities). This information is based on RCOG Green-top Guideline No. 52.

Postpartum Haemorrhage: Causes, Risk Factors, and Management

Postpartum haemorrhage (PPH) is a condition characterized by excessive blood loss of more than 500 ml after a vaginal delivery. It can be primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia. Management of PPH is a life-threatening emergency that requires immediate involvement of senior staff. The ABC approach is used, and bloods are taken, including group and save. Medical management includes IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options are considered if medical management fails to control the bleeding. Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis.

Understanding Postpartum Haemorrhage

Postpartum haemorrhage is a serious condition that can occur after vaginal delivery. It is important to understand the causes, risk factors, and management of this condition to ensure prompt and effective treatment. Primary PPH is caused by the 4 Ts, with uterine atony being the most common cause. Risk factors for primary PPH include previous PPH, prolonged labour, and emergency Caesarean section. Management of PPH is a life-threatening emergency that requires immediate involvement of senior staff. Medical management includes IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options are considered if medical management fails to control the bleeding. Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to be aware of the signs and symptoms of PPH and seek medical attention immediately if they occur.

According to NICE guidelines, Labetalol is the preferred medication for treating hypertension in pregnant women. While Nifedipine is considered safe for use during pregnancy, it is not the first option. However, Ramipril and Candesartan should not be used during pregnancy due to potential risks.

Hypertension during pregnancy is a common condition that can be managed effectively with proper care. In normal pregnancy, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, if a pregnant woman develops hypertension, it is usually defined as a systolic blood pressure of over 140 mmHg or a diastolic blood pressure of over 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from booking readings can also indicate hypertension.

After confirming hypertension, the patient should be categorized into one of three groups: pre-existing hypertension, pregnancy-induced hypertension (PIH), or pre-eclampsia. PIH, also known as gestational hypertension, occurs in 3-5% of pregnancies and is more common in older women. If a pregnant woman takes an ACE inhibitor or angiotensin II receptor blocker for pre-existing hypertension, it should be stopped immediately, and alternative antihypertensives should be started while awaiting specialist review.

Pregnancy-induced hypertension in association with proteinuria, which occurs in around 5% of pregnancies, may also cause oedema. The 2010 NICE guidelines recommend oral labetalol as the first-line treatment for hypertension during pregnancy. Oral nifedipine and hydralazine may also be used, depending on the patient’s medical history. It is important to manage hypertension during pregnancy effectively to reduce the risk of complications and ensure the health of both the mother and the baby.

Following ovulation, the body temperature increases, which can be used as a method of behavioural contraception. By measuring and plotting the temperature each day, patients can identify their fertile window and use alternative contraception during this time. However, this method is less effective than hormonal contraception. The rise in temperature is due to the increase in progesterone levels, which is maintained after fertilisation. The initiation of the follicular phase and menses do not cause a rapid rise in temperature, as the progesterone levels are typically low during these phases. A peak in oestrogen does not affect the body temperature.

Phases of the Menstrual Cycle

The menstrual cycle is a complex process that can be divided into four phases: menstruation, follicular phase, ovulation, and luteal phase. During the follicular phase, a number of follicles develop in the ovaries, with one follicle becoming dominant around the mid-follicular phase. At the same time, the endometrium undergoes proliferation. This phase is characterized by a rise in follicle-stimulating hormone (FSH), which results in the development of follicles that secrete oestradiol. When the egg has matured, it secretes enough oestradiol to trigger the acute release of luteinizing hormone (LH), which leads to ovulation.

During the luteal phase, the corpus luteum secretes progesterone, which causes the endometrium to change to a secretory lining. If fertilization does not occur, the corpus luteum will degenerate, and progesterone levels will fall. Oestradiol levels also rise again during the luteal phase. Cervical mucus thickens and forms a plug across the external os following menstruation. Just prior to ovulation, the mucus becomes clear, acellular, low viscosity, and stretchy. Under the influence of progesterone, it becomes thick, scant, and tacky. Basal body temperature falls prior to ovulation due to the influence of oestradiol and rises following ovulation in response to higher progesterone levels. Understanding the phases of the menstrual cycle is important for women’s health and fertility.

During pregnancy, the main contributor to the increased cardiac output is the increased stroke volume, which is caused by the activation of the renin-angiotensin system and the subsequent increase in plasma volume. Although the heart rate also increases slightly, it is not as significant as the increase in stroke volume. Therefore, the major contributor to the increased cardiac output is the stroke volume.

The statements ‘decreased heart rate’ and ‘increased peripheral resistance’ are incorrect. In fact, peripheral resistance decreases due to progesterone, which contributes to the normal decrease in blood pressure during pregnancy. Peripheral resistance is more concerned with blood pressure.

Pregnancy also causes various physiological changes, including increased uterine size, cervical ectropion, reduced cervical collagen, and increased vaginal discharge. Cardiovascular and haemodynamic changes include increased plasma volume, anaemia, increased white cell count, platelets, ESR, cholesterol, and fibrinogen, as well as decreased albumin, urea, and creatinine. Progesterone-related effects, such as muscle relaxation, can cause decreased blood pressure, constipation, ureteral dilation, bladder relaxation, biliary stasis, and increased tidal volume.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

The inguinal nodes are responsible for draining the scrotum.

Anatomy of the Scrotum and Testes

The scrotum is composed of skin and dartos fascia, with an arterial supply from the anterior and posterior scrotal arteries. It is also the site of lymphatic drainage to the inguinal lymph nodes. The testes are surrounded by the tunica vaginalis, a closed peritoneal sac, with the parietal layer adjacent to the internal spermatic fascia. The testicular arteries arise from the aorta, just below the renal arteries, and the pampiniform plexus drains into the testicular veins. The left testicular vein drains into the left renal vein, while the right testicular vein drains into the inferior vena cava. Lymphatic drainage occurs to the para-aortic nodes.

The spermatic cord is formed by the vas deferens and is covered by the internal spermatic fascia, cremasteric fascia, and external spermatic fascia. The cord contains the vas deferens, testicular artery, artery of vas deferens, cremasteric artery, pampiniform plexus, sympathetic nerve fibers, genital branch of the genitofemoral nerve, and lymphatic vessels. The vas deferens transmits sperm and accessory gland secretions, while the testicular artery supplies the testis and epididymis. The cremasteric artery arises from the inferior epigastric artery, and the pampiniform plexus is a venous plexus that drains into the right or left testicular vein. The sympathetic nerve fibers lie on the arteries, while the parasympathetic fibers lie on the vas. The genital branch of the genitofemoral nerve supplies the cremaster. Lymphatic vessels drain to lumbar and para-aortic nodes.

Understanding Absence of the Vas Deferens

Absence of the vas deferens is a condition that can occur either unilaterally or bilaterally. In 40% of cases, the cause is due to mutations in the CFTR gene, which is associated with cystic fibrosis. However, in some non-CF cases, the absence of the vas deferens is due to unilateral renal agenesis. Despite this condition, assisted conception may still be possible through sperm harvesting.

It is important to understand the underlying causes of absence of the vas deferens, as it can impact fertility and the ability to conceive. While the condition may be associated with cystic fibrosis, it can also occur independently. However, with advancements in assisted reproductive technologies, individuals with this condition may still have options for starting a family. By seeking medical advice and exploring available options, individuals can make informed decisions about their reproductive health.

Monozygotic twins with one chorion and two amnions are the result of division between days 4 and 8 after fertilization. This type of twinning has diamniotic, monochorionic placentation. Division between days 8 and 12 after fertilization leads to monozygotic twins with monoamniotic, monochorionic placentation, while fertilization of two separate eggs with two separate sperm results in dizygotic twins with diamniotic, dichorionic placentation. It’s important to note that division between days 4 and 8 after fertilization does not result in dizygotic twins.

Twin Pregnancies: Incidence, Types, and Complications

Twin pregnancies occur in approximately 1 out of 105 pregnancies, with the majority being dizygotic or non-identical twins. Monozygotic or identical twins, on the other hand, develop from a single ovum that has divided to form two embryos. However, monoamniotic monozygotic twins are associated with increased risks of spontaneous miscarriage, perinatal mortality rate, malformations, intrauterine growth restriction, prematurity, and twin-to-twin transfusions. The incidence of dizygotic twins is increasing due to infertility treatment, and predisposing factors include previous twins, family history, increasing maternal age, multigravida, induced ovulation, in-vitro fertilisation, and race, particularly Afro-Caribbean.

Antenatal complications of twin pregnancies include polyhydramnios, pregnancy-induced hypertension, anaemia, and antepartum haemorrhage. Fetal complications include perinatal mortality, prematurity, light-for-date babies, and malformations, especially in monozygotic twins. Labour complications may also arise, such as postpartum haemorrhage, malpresentation, cord prolapse, and entanglement.

Management of twin pregnancies involves rest, ultrasound for diagnosis and monthly checks, additional iron and folate, more antenatal care, and precautions during labour, such as having two obstetricians present. Most twins deliver by 38 weeks, and if longer, most are induced at 38-40 weeks. Overall, twin pregnancies require close monitoring and management to ensure the best possible outcomes for both mother and babies.

Effective contraception with the progestogen-only pill can be achieved immediately if it is started on the first to the fifth day of menstruation. However, if it is started at any other time or if the patient is uncertain, it is recommended to use additional contraceptive methods like condoms or abstinence for the first 48 hours.

Counselling for Women Considering the Progestogen-Only Pill

Women who are considering taking the progestogen-only pill (POP) should receive counselling on various aspects of the medication. One of the most common potential adverse effects is irregular vaginal bleeding. It is important to note that the POP should be taken at the same time every day, without a pill-free break, unlike the combined oral contraceptive (COC).

When starting the POP, immediate protection is provided if commenced up to and including day 5 of the cycle. If started later, additional contraceptive methods such as condoms should be used for the first 2 days. If switching from a COC, immediate protection is provided if continued directly from the end of a pill packet.

In case of missed pills, if the delay is less than 3 hours, the pill should be taken as usual. If the delay is more than 3 hours, the missed pill should be taken as soon as possible, and extra precautions such as condoms should be used until pill taking has been re-established for 48 hours.

It is important to note that antibiotics have no effect on the POP, unless the antibiotic alters the P450 enzyme system. Liver enzyme inducers may reduce the effectiveness of the POP. In case of diarrhoea and vomiting, the POP should be continued, but it should be assumed that pills have been missed.

Finally, it is important to discuss sexually transmitted infections (STIs) with healthcare providers when considering the POP. By providing comprehensive counselling, women can make informed decisions about whether the POP is the right contraceptive choice for them.

Anatomy of the Scrotum and Testes

The scrotum is composed of skin and dartos fascia, with an arterial supply from the anterior and posterior scrotal arteries. It is also the site of lymphatic drainage to the inguinal lymph nodes. The testes are surrounded by the tunica vaginalis, a closed peritoneal sac, with the parietal layer adjacent to the internal spermatic fascia. The testicular arteries arise from the aorta, just below the renal arteries, and the pampiniform plexus drains into the testicular veins. The left testicular vein drains into the left renal vein, while the right testicular vein drains into the inferior vena cava. Lymphatic drainage occurs to the para-aortic nodes.

The spermatic cord is formed by the vas deferens and is covered by the internal spermatic fascia, cremasteric fascia, and external spermatic fascia. The cord contains the vas deferens, testicular artery, artery of vas deferens, cremasteric artery, pampiniform plexus, sympathetic nerve fibers, genital branch of the genitofemoral nerve, and lymphatic vessels. The vas deferens transmits sperm and accessory gland secretions, while the testicular artery supplies the testis and epididymis. The cremasteric artery arises from the inferior epigastric artery, and the pampiniform plexus is a venous plexus that drains into the right or left testicular vein. The sympathetic nerve fibers lie on the arteries, while the parasympathetic fibers lie on the vas. The genital branch of the genitofemoral nerve supplies the cremaster. Lymphatic vessels drain to lumbar and para-aortic nodes.

The pelvic wall is connected to the uterus, fallopian tubes, and ovaries through the broad ligament. While the cardinal and suspensory ligaments also attach to the pelvic wall, they are only connected to one structure each: the cervix for the cardinal ligament and the ovaries for the suspensory ligament. The broad ligament encompasses the round ligament, ovarian ligament, and suspensory ligament of the ovaries.

Pelvic Ligaments and their Connections

Pelvic ligaments are structures that connect various organs within the female reproductive system to the pelvic wall. These ligaments play a crucial role in maintaining the position and stability of these organs. There are several types of pelvic ligaments, each with its own unique function and connection.

The broad ligament connects the uterus, fallopian tubes, and ovaries to the pelvic wall, specifically the ovaries. The round ligament connects the uterine fundus to the labia majora, but does not connect to any other structures. The cardinal ligament connects the cervix to the lateral pelvic wall and is responsible for supporting the uterine vessels. The suspensory ligament of the ovaries connects the ovaries to the lateral pelvic wall and supports the ovarian vessels. The ovarian ligament connects the ovaries to the uterus, but does not connect to any other structures. Finally, the uterosacral ligament connects the cervix and posterior vaginal dome to the sacrum, but does not connect to any other structures.

Overall, pelvic ligaments are essential for maintaining the proper position and function of the female reproductive organs. Understanding the connections between these ligaments and the structures they support is crucial for diagnosing and treating any issues that may arise.

Shoulder dystocia, a complication of obstructed labor, is more likely to occur in cases of gestational diabetes and macrosomia. This is because a larger fetal shoulder can obstruct the maternal pubic symphysis. Low birth weight babies are at a higher risk of umbilical cord prolapse, while uterine rupture is typically associated with previous Caesarean section or myomectomy. Although disseminated intravascular coagulation and amniotic fluid embolism are serious obstetric emergencies, there is no indication in the patient’s history of an increased risk for these conditions.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the baby.

There are several risk factors that increase the likelihood of shoulder dystocia, including fetal macrosomia (large baby), high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior medical assistance immediately. The McRoberts’ maneuver is often used to help deliver the baby. This involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant harm to the mother. Oxytocin administration is not effective in treating shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury or neonatal death for the baby. It is important to manage shoulder dystocia promptly and effectively to minimize these risks.

Pelvic inflammatory disease can be a challenging diagnosis for emergency practitioners, as it presents with vague abdominal pain that can be mistaken for a surgical or gynecological issue. While CT scans are not ideal for young patients due to the risk of radiation exposure to the sex organs, they can reveal common findings for pelvic inflammatory disease, such as free fluid in the pouch of Douglas, pelvic fat stranding, tubo-ovarian abscesses, and fallopian tube thickening of more than 5 mm. In contrast, CT scans for appendicitis may show appendiceal dilatation, thickening of the caecal apex with a bar sign, periappendiceal fat stranding and phlegmon, and focal wall nonenhancement in cases of gangrenous appendix. The most common cause of pelvic inflammatory disease is Chlamydia trachomatis, followed by Neisseria gonorrhoeae and Mycobacterium tuberculosis. In cases of appendicitis, Escherichia coli is the most likely causative organism, with rare cases caused by other organisms.

Pelvic inflammatory disease (PID) is a condition where the female pelvic organs, including the uterus, fallopian tubes, ovaries, and surrounding peritoneum, become infected and inflamed. It is typically caused by an infection that spreads from the endocervix. The most common causative organism is Chlamydia trachomatis, followed by Neisseria gonorrhoeae, Mycoplasma genitalium, and Mycoplasma hominis. Symptoms of PID include lower abdominal pain, fever, dyspareunia, dysuria, menstrual irregularities, vaginal or cervical discharge, and cervical excitation.

To diagnose PID, a pregnancy test should be done to rule out an ectopic pregnancy, and a high vaginal swab should be taken to screen for Chlamydia and gonorrhoeae. However, these tests may often be negative, so consensus guidelines recommend having a low threshold for treatment due to the potential complications of untreated PID. Management typically involves oral ofloxacin and oral metronidazole or intramuscular ceftriaxone, oral doxycycline, and oral metronidazole. In mild cases of PID, intrauterine contraceptive devices may be left in, but the evidence is limited, and removal of the IUD may be associated with better short-term clinical outcomes according to recent guidelines.

Complications of PID include perihepatitis (Fitz-Hugh Curtis Syndrome), which occurs in around 10% of cases and is characterized by right upper quadrant pain that may be confused with cholecystitis, infertility (with a risk as high as 10-20% after a single episode), chronic pelvic pain, and ectopic pregnancy.

Shoulder dystocia is the labour complication discussed in this case, and it is more likely to occur in cases of foetal macrosomia. This is because larger babies have a greater shoulder diameter, making it more difficult for the shoulders to pass through the pelvic outlet.

Maternal pre-eclampsia is a risk factor for small for gestational age (SGA) pregnancies, but it is not directly linked to shoulder dystocia.

Obstetric cholestasis is a liver disorder that can occur during pregnancy, but it does not increase the risk of shoulder dystocia.

While a previous caesarean section may increase the likelihood of placenta praevia, placenta accreta, or uterine rupture, it is not a direct risk factor for shoulder dystocia.

A previous post-term delivery may increase the likelihood of future post-term deliveries, but it does not directly increase the risk of shoulder dystocia.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the baby.

There are several risk factors that increase the likelihood of shoulder dystocia, including fetal macrosomia (large baby), high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior medical assistance immediately. The McRoberts’ maneuver is often used to help deliver the baby. This involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant harm to the mother. Oxytocin administration is not effective in treating shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury or neonatal death for the baby. It is important to manage shoulder dystocia promptly and effectively to minimize these risks.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

The patient is exhibiting symptoms that are indicative of pre-eclampsia, such as headache, abdominal pain, and blurred vision. However, the presence of jaundice suggests that the patient is actually suffering from HELLP syndrome, which is a complication during pregnancy that involves haemolysis, elevated liver enzymes, and low platelets. This condition often occurs in conjunction with pregnancy-induced hypertension or pre-eclampsia.

Pre-eclampsia is a pregnancy-related disorder that is characterized by high blood pressure and damage to another organ system, typically the kidneys, which is evidenced by proteinuria. This condition typically develops after the 20th week of pregnancy in women who previously had normal blood pressure.

Jaundice During Pregnancy

During pregnancy, jaundice can occur due to various reasons. One of the most common liver diseases during pregnancy is intrahepatic cholestasis of pregnancy, which affects around 1% of pregnancies and is usually seen in the third trimester. Symptoms include itching, especially in the palms and soles, and raised bilirubin levels. Ursodeoxycholic acid is used for symptomatic relief, and women are typically induced at 37 weeks. However, this condition can increase the risk of stillbirth.

Acute fatty liver of pregnancy is a rare complication that can occur in the third trimester or immediately after delivery. Symptoms include abdominal pain, nausea, vomiting, headache, jaundice, and hypoglycemia. ALT levels are typically elevated. Supportive care is the initial management, and delivery is the definitive management once the patient is stabilized.

Gilbert’s and Dubin-Johnson syndrome may also be exacerbated during pregnancy. Additionally, HELLP syndrome, which stands for Haemolysis, Elevated Liver enzymes, Low Platelets, can also cause jaundice during pregnancy. It is important to monitor liver function tests and seek medical attention if any symptoms of jaundice occur during pregnancy.

The cessation of oestradiol and progesterone production in the ovaries, which can be caused naturally or by medical intervention, leads to menopause. This decrease in hormone production often results in elevated levels of FSH and LH.

Understanding Menopause and Contraception

Menopause is a natural biological process that marks the end of a woman’s reproductive years. It typically occurs when a woman reaches the age of 51 in the UK. However, prior to menopause, women may experience a period known as the climacteric. During this time, ovarian function starts to decline, and women may experience symptoms such as hot flashes, mood swings, and vaginal dryness.

It is important for women to understand that they can still become pregnant during the climacteric period. Therefore, it is recommended to use effective contraception until a certain period of time has passed. Women over the age of 50 should use contraception for 12 months after their last period, while women under the age of 50 should use contraception for 24 months after their last period. By understanding menopause and the importance of contraception during the climacteric period, women can make informed decisions about their reproductive health.

The ectocervix is covered by a layer of stratified squamous non-keratinized epithelium, while the endocervix is lined with simple columnar epithelium that secretes mucus.

Abnormal cells are often found in the transformation zone, which is the area where the stratified squamous non-keratinized cells transition into the mucus-secreting simple columnar cells.

Other examples of epithelial cell types include stratified squamous keratinized epithelium found on palmer skin, and stratified columnar non-keratinized epithelium found on the conjunctiva of the eye.

Understanding Cervical Cancer and its Risk Factors

Cervical cancer is a type of cancer that affects the cervix, which is the lower part of the uterus. It is most commonly diagnosed in women under the age of 45, with the highest incidence rates occurring in those aged 25-29. The cancer can be divided into two types: squamous cell cancer and adenocarcinoma. Symptoms of cervical cancer may include abnormal vaginal bleeding, such as postcoital, intermenstrual, or postmenopausal bleeding, as well as vaginal discharge.

The most significant risk factor for cervical cancer is infection with the human papillomavirus (HPV), particularly serotypes 16, 18, and 33. Other risk factors include smoking, human immunodeficiency virus (HIV), early first intercourse, many sexual partners, high parity, and lower socioeconomic status. The mechanism by which HPV causes cervical cancer involves the production of oncogenes E6 and E7 by HPV 16 and 18, respectively. E6 inhibits the p53 tumour suppressor gene, while E7 inhibits the RB suppressor gene.

While the strength of the association between combined oral contraceptive pill use and cervical cancer is sometimes debated, a large study published in the Lancet in 2007 confirmed the link. It is important for women to undergo routine cervical cancer screening to detect any abnormalities early on and to discuss any potential risk factors with their healthcare provider.

Smoking while pregnant has been linked to the birth of a Small for Gestational Age baby. This is indicated by the baby’s birth weight being below the 10th percentile and fetal measurements suggesting asymmetrical intrauterine growth restriction (IUGR), with the head circumference being significantly higher than the abdominal circumference and femur length. Maternal smoking is a possible cause of the baby’s small size, as it has been associated with reduced birth weight and asymmetrical IUGR. Multiple gestation is a known risk factor for fetal growth restriction, but singleton gestation is not. Maternal rubella infection and advanced maternal age may also cause small for gestational age babies, but these are less likely causes in this case as the mother’s immunisations are up to date and she is only 23 years old.

Small for Gestational Age (SGA) is a statistical definition used to describe babies who are smaller than expected for their gestational age. Although there is no universally agreed percentile, the 10th percentile is often used, meaning that 10% of normal babies will be below this threshold. SGA can be determined either antenatally or postnatally. There are two types of SGA: symmetrical and asymmetrical. Symmetrical SGA occurs when the fetal head circumference and abdominal circumference are equally small, while asymmetrical SGA occurs when the abdominal circumference slows relative to the increase in head circumference.

There are various causes of SGA, including incorrect dating, constitutionally small (normal) babies, and abnormal fetuses. Symmetrical SGA is more common and can be caused by idiopathic factors, race, sex, placental insufficiency, pre-eclampsia, chromosomal and congenital abnormalities, toxins such as smoking and heroin, and infections such as CMV, parvovirus, rubella, syphilis, and toxoplasmosis. Asymmetrical SGA is less common and can be caused by toxins such as alcohol, cigarettes, and heroin, chromosomal and congenital abnormalities, and infections.

The management of SGA depends on the type and cause. For symmetrical SGA, most cases represent the lower limits of the normal range and require fortnightly ultrasound growth assessments to demonstrate normal growth rates. Pathological causes should be ruled out by checking maternal blood for infections and searching the fetus carefully with ultrasound for markers of chromosomal abnormality. Asymmetrical SGA also requires fortnightly ultrasound growth assessments, as well as biophysical profiles and Doppler waveforms from umbilical circulation to look for absent end-diastolic flow. If results are sub-optimal, delivery may be considered.

Placental abruption, placenta praevia, and ectopic pregnancy can cause vaginal bleeding, but they do not typically result in a non-tender, large-for-dates uterus. Gestational diabetes is not associated with vaginal bleeding or hyperemesis.

Molar pregnancy is a type of gestational trophoblastic disease that occurs when there is an abnormal fertilization of an empty ovum. There are two types of molar pregnancies: complete and partial. Complete hydatidiform moles have a karyotype of 46 XX or 46 XY, with all genetic material coming from the father. Partial hydatidiform moles have a karyotype of 69 XXX or 69 XXY and contain both maternal and paternal chromosomes. Neither type of molar pregnancy can result in a viable fetus.

The most common symptom of a molar pregnancy is vaginal bleeding, which can range from light to heavy. In about 25% of complete molar pregnancies, the uterus may be larger than expected for the gestational age. Complete hydatidiform moles produce high levels of beta hCG due to the large amounts of abnormal chorionic villi, which can lead to hyperemesis, hyperthyroidism, and other symptoms. Women who are under 20 years old or over 35 years old are at a higher risk of having a molar pregnancy.

Gestational trophoblastic disorders refer to a range of conditions that originate from the placental trophoblast. These disorders include complete hydatidiform mole, partial hydatidiform mole, and choriocarcinoma. Complete hydatidiform mole is a benign tumor of trophoblastic material that occurs when an empty egg is fertilized by a single sperm that duplicates its own DNA, resulting in all 46 chromosomes being of paternal origin. Symptoms of this disorder include bleeding in the first or early second trimester, exaggerated pregnancy symptoms, a large uterus for dates, and high levels of human chorionic gonadotropin (hCG) in the blood. Hypertension and hyperthyroidism may also be present. Urgent referral to a specialist center is necessary, and evacuation of the uterus is performed. Effective contraception is recommended to avoid pregnancy in the next 12 months. About 2-3% of cases may progress to choriocarcinoma. In partial mole, a normal haploid egg may be fertilized by two sperms or one sperm with duplication of paternal chromosomes, resulting in DNA that is both maternal and paternal in origin. Fetal parts may be visible, and the condition is usually triploid.

postpartum haemorrhage (PPH) can occur when the uterus fails to contract after childbirth. To manage this condition, healthcare providers typically take an ABCDE approach and administer drugs that stimulate uterine contractions. One such drug is a synthetic form of oxytocin called Syntocinon, which can be given intravenously. Ergometrine, another drug that stimulates uterine contractions, is often given alongside Syntocinon. Tranexamic acid, a synthetic lysine analogue that inhibits the fibrinolytic system, may also be administered. If PPH persists, a synthetic prostaglandin like carboprost may be given. Prostacyclin (PGI2) has no effect on uterine contractions and is not used to manage PPH. Dopamine and prolactin, which regulate lactation, are not involved in controlling postpartum haemorrhage.

Understanding Oxytocin: The Hormone Responsible for Let-Down Reflex and Uterine Contraction

Oxytocin is a hormone composed of nine amino acids that is produced by the paraventricular nuclei of the hypothalamus and released by the posterior pituitary gland. Its primary function is to stimulate the let-down reflex of lactation by causing the contraction of the myoepithelial cells of the alveoli of the mammary glands. It also promotes uterine contraction, which is essential during childbirth.

Oxytocin secretion increases during infant suckling and may also increase during orgasm. A synthetic version of oxytocin, called Syntocinon, is commonly administered during the third stage of labor and is used to manage postpartum hemorrhage. However, oxytocin administration can also have adverse effects, such as uterine hyperstimulation, water intoxication, and hyponatremia.

In summary, oxytocin plays a crucial role in lactation and childbirth. Its secretion is regulated by infant suckling and can also increase during sexual activity. While oxytocin administration can be beneficial in certain situations, it is important to be aware of its potential adverse effects.

The patient’s symptom is non-specific and could have various causes. However, given her age and the fact that she has lost a friend to ovarian cancer, it is reasonable to perform a simple test to rule out this possibility and alleviate her concerns. It is important to note that the patient does not exhibit any other common symptoms associated with ovarian cancer, such as weight loss.

CA-125 is a tumour marker for ovarian cancer, while CA19-9 is associated with pancreatic cancer. CEA is a marker for bowel cancer, and colonoscopy may be considered if the patient presents with additional symptoms that suggest gastrointestinal disease.

Understanding Ovarian Cancer: Risk Factors, Symptoms, and Management

Ovarian cancer is a type of cancer that affects women, with the peak age of incidence being 60 years. It is the fifth most common malignancy in females and carries a poor prognosis due to late diagnosis. Around 90% of ovarian cancers are epithelial in origin, with 70-80% of cases being due to serous carcinomas. Interestingly, recent studies suggest that the distal end of the fallopian tube is often the site of origin of many ‘ovarian’ cancers.

There are several risk factors associated with ovarian cancer, including a family history of mutations of the BRCA1 or the BRCA2 gene, early menarche, late menopause, and nulliparity. Clinical features of ovarian cancer are notoriously vague and can include abdominal distension and bloating, abdominal and pelvic pain, urinary symptoms, early satiety, and diarrhea.

To diagnose ovarian cancer, a CA125 test is usually done initially. If the CA125 level is raised, an urgent ultrasound scan of the abdomen and pelvis should be ordered. However, a CA125 should not be used for screening for ovarian cancer in asymptomatic women. Diagnosis is difficult and usually involves diagnostic laparotomy.

Management of ovarian cancer usually involves a combination of surgery and platinum-based chemotherapy. The prognosis for ovarian cancer is poor, with 80% of women having advanced disease at presentation and the all stage 5-year survival being 46%. It is traditionally taught that infertility treatment increases the risk of ovarian cancer, as it increases the number of ovulations. However, recent evidence suggests that there is not a significant link. The combined oral contraceptive pill reduces the risk (fewer ovulations) as does having many pregnancies.

The external oblique aponeurosis provides the outermost layer of the spermatic cord, which is acquired during its passage through the superficial inguinal ring.

Anatomy of the Scrotum and Testes

The scrotum is composed of skin and dartos fascia, with an arterial supply from the anterior and posterior scrotal arteries. It is also the site of lymphatic drainage to the inguinal lymph nodes. The testes are surrounded by the tunica vaginalis, a closed peritoneal sac, with the parietal layer adjacent to the internal spermatic fascia. The testicular arteries arise from the aorta, just below the renal arteries, and the pampiniform plexus drains into the testicular veins. The left testicular vein drains into the left renal vein, while the right testicular vein drains into the inferior vena cava. Lymphatic drainage occurs to the para-aortic nodes.

The spermatic cord is formed by the vas deferens and is covered by the internal spermatic fascia, cremasteric fascia, and external spermatic fascia. The cord contains the vas deferens, testicular artery, artery of vas deferens, cremasteric artery, pampiniform plexus, sympathetic nerve fibers, genital branch of the genitofemoral nerve, and lymphatic vessels. The vas deferens transmits sperm and accessory gland secretions, while the testicular artery supplies the testis and epididymis. The cremasteric artery arises from the inferior epigastric artery, and the pampiniform plexus is a venous plexus that drains into the right or left testicular vein. The sympathetic nerve fibers lie on the arteries, while the parasympathetic fibers lie on the vas. The genital branch of the genitofemoral nerve supplies the cremaster. Lymphatic vessels drain to lumbar and para-aortic nodes.

Ectopic pregnancy is more likely to occur in women who have had pelvic inflammatory disease, which can cause damage to the tubes. Other risk factors include a history of ectopic pregnancy, the presence of an intrauterine contraceptive device, endometriosis, and undergoing in-vitro fertilization. However, the use of antibiotics, condoms, and being young are not considered established risk factors. While endometriosis can increase the risk of ectopic pregnancy, this patient does not have a history of symptoms associated with the condition.

Understanding Ectopic Pregnancy: Incidence and Risk Factors

Ectopic pregnancy occurs when a fertilized egg implants outside the uterus, usually in the fallopian tubes. This condition is a serious medical emergency that requires immediate attention. According to epidemiological studies, ectopic pregnancy occurs in approximately 0.5% of all pregnancies.

Several risk factors can increase the likelihood of ectopic pregnancy. These include damage to the fallopian tubes due to pelvic inflammatory disease or surgery, a history of previous ectopic pregnancy, endometriosis, the use of intrauterine contraceptive devices (IUCDs), and the progesterone-only pill. In vitro fertilization (IVF) also increases the risk of ectopic pregnancy, with approximately 3% of IVF pregnancies resulting in ectopic implantation.

It is important for women to be aware of the risk factors associated with ectopic pregnancy and to seek medical attention immediately if they experience symptoms such as abdominal pain, vaginal bleeding, or shoulder pain. Early diagnosis and treatment can help prevent serious complications and improve outcomes for both the mother and the fetus.

Miscarriage is not caused by a single factor, but rather by a combination of risk factors. Women over the age of 35 and men over the age of 40 are at a significantly higher risk of experiencing a miscarriage. It is important to note that activities such as exercise, emotional stress, consuming spicy foods, and engaging in sexual intercourse do not increase the risk of miscarriage.

Miscarriage: Understanding the Epidemiology

Miscarriage, also known as spontaneous abortion, refers to the natural expulsion of the products of conception before the 24th week of pregnancy. It is a common occurrence, with approximately 15-20% of diagnosed pregnancies ending in miscarriage during the early stages. To avoid any confusion, the term miscarriage is often used instead of abortion.

Studies show that up to 50% of conceptions fail to develop into a blastocyst within 14 days. This highlights the importance of early detection and monitoring during pregnancy. Additionally, recurrent spontaneous miscarriage affects approximately 1% of women, which can be a distressing and emotionally challenging experience.

Understanding the epidemiology of miscarriage is crucial in providing appropriate care and support for women who experience this loss. With proper medical attention and emotional support, women can navigate through this difficult time and move forward with hope and healing.

Breast Milk lactoferrin facilitates the quick absorption of iron in the gut, while simultaneously limiting the amount of iron accessible to gut bacteria due to its antibacterial properties. Additionally, lactoferrin has been found to promote bone health by increasing bone formation and reducing bone resorption.

Advantages and Disadvantages of Breastfeeding

Breastfeeding has numerous advantages for both the mother and the baby. For the mother, it promotes bonding with the baby and helps with the involution of the uterus. It also provides protection against breast and ovarian cancer and is a cheap alternative to formula feeding as there is no need to sterilize bottles. However, it should not be relied upon as a contraceptive method as it is unreliable.

Breast milk contains immunological components such as IgA, lysozyme, and lactoferrin that protect mucosal surfaces, have bacteriolytic properties, and ensure rapid absorption of iron so it is not available to bacteria. This reduces the incidence of ear, chest, and gastrointestinal infections, as well as eczema, asthma, and type 1 diabetes mellitus. Breastfeeding also reduces the incidence of sudden infant death syndrome.

One of the advantages of breastfeeding is that the baby is in control of how much milk it takes. However, there are also disadvantages such as the transmission of drugs and infections such as HIV. Prolonged breastfeeding may also lead to nutrient inadequacies such as vitamin D and vitamin K deficiencies, as well as breast milk jaundice.

In conclusion, while breastfeeding has numerous advantages, it is important to be aware of the potential disadvantages and to consult with a healthcare professional to ensure that both the mother and the baby are receiving adequate nutrition and care.

Breast malignancy often leads to skin dimpling and nipple retraction, which are caused by the tumour infiltrating the breast ligaments and ducts. The axillary contents are enclosed by the clavipectoral fascia, and the breast’s lymphatic drainage occurs in both the axilla and internal mammary chain. The breast is highly vascularized, with the internal mammary artery being a subclavian artery branch.

The breast is situated on a layer of pectoral fascia and is surrounded by the pectoralis major, serratus anterior, and external oblique muscles. The nerve supply to the breast comes from branches of intercostal nerves from T4-T6, while the arterial supply comes from the internal mammary (thoracic) artery, external mammary artery (laterally), anterior intercostal arteries, and thoraco-acromial artery. The breast’s venous drainage is through a superficial venous plexus to subclavian, axillary, and intercostal veins. Lymphatic drainage occurs through the axillary nodes, internal mammary chain, and other lymphatic sites such as deep cervical and supraclavicular fossa (later in disease).

The preparation for lactation involves the hormones oestrogen, progesterone, and human placental lactogen. Oestrogen promotes duct development in high concentrations, while high levels of progesterone stimulate the formation of lobules. Human placental lactogen prepares the mammary glands for lactation. The two hormones involved in stimulating lactation are prolactin and oxytocin. Prolactin causes milk secretion, while oxytocin causes contraction of the myoepithelial cells surrounding the mammary alveoli to result in milk ejection from the breast. Suckling of the baby stimulates the mechanoreceptors in the nipple, resulting in the release of both prolactin and oxytocin from the pituitary gland (anterior and posterior parts respectively).

The symptoms and indications described indicate that the patient is suffering from severe pre-eclampsia. It should be noted that not all antihypertensive drugs are safe for use during pregnancy due to their teratogenic effects. Therefore, hydrocortisone is the only drug mentioned that is not an antihypertensive. Among the antihypertensive drugs mentioned, labetalol is the most suitable option as it is recommended as a first-line drug for managing severe hypertension in pregnant patients according to NICE guidelines.

Hypertension during pregnancy is a common condition that can be managed effectively with proper care. In normal pregnancy, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, if a pregnant woman develops hypertension, it is usually defined as a systolic blood pressure of over 140 mmHg or a diastolic blood pressure of over 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from booking readings can also indicate hypertension.

After confirming hypertension, the patient should be categorized into one of three groups: pre-existing hypertension, pregnancy-induced hypertension (PIH), or pre-eclampsia. PIH, also known as gestational hypertension, occurs in 3-5% of pregnancies and is more common in older women. If a pregnant woman takes an ACE inhibitor or angiotensin II receptor blocker for pre-existing hypertension, it should be stopped immediately, and alternative antihypertensives should be started while awaiting specialist review.

Pregnancy-induced hypertension in association with proteinuria, which occurs in around 5% of pregnancies, may also cause oedema. The 2010 NICE guidelines recommend oral labetalol as the first-line treatment for hypertension during pregnancy. Oral nifedipine and hydralazine may also be used, depending on the patient’s medical history. It is important to manage hypertension during pregnancy effectively to reduce the risk of complications and ensure the health of both the mother and the baby.

To obtain fluid from the rectouterine pouch, a needle is inserted through the posterior fornix of the vagina.

The vagina has four fornices, including the anterior, posterior, and two lateral fornices. The anterior fornix of the vagina is closely associated with the vesicouterine pouch.

Culdocentesis is a procedure that involves using a needle to extract fluid from the rectouterine pouch (also known as the pouch of Douglas) through the posterior fornix of the vagina.

Culdocentesis is now mostly replaced by ultrasound examination and minimally invasive surgery, such as in cases of ectopic pregnancy.

Anatomy of the Uterus

The uterus is a female reproductive organ that is located within the pelvis and is covered by the peritoneum. It is supplied with blood by the uterine artery, which runs alongside the uterus and anastomoses with the ovarian artery. The uterus is supported by various ligaments, including the central perineal tendon, lateral cervical, round, and uterosacral ligaments. The ureter is located close to the uterus, and injuries to the ureter can occur when there is pathology in the area.

The uterus is typically anteverted and anteflexed in most women. Its topography can be visualized through imaging techniques such as ultrasound or MRI. Understanding the anatomy of the uterus is important for diagnosing and treating various gynecological conditions.

The initial step recommended for managing shoulder dystocia is the use of McRobert’s manoeuvre. This involves the mother’s hips being flexed towards her abdomen and abducting them outwards, typically with the assistance of two individuals. By doing so, the pelvis is tilted upwards, causing the pubic symphysis to move in the same direction. This results in an increase in the functional dimensions of the pelvic outlet, providing more space for the anterior shoulder to be delivered. McRobert’s manoeuvre is successful in the majority of cases of shoulder dystocia and should be performed before any invasive or potentially harmful procedures.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the baby.

There are several risk factors that increase the likelihood of shoulder dystocia, including fetal macrosomia (large baby), high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior medical assistance immediately. The McRoberts’ maneuver is often used to help deliver the baby. This involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant harm to the mother. Oxytocin administration is not effective in treating shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury or neonatal death for the baby. It is important to manage shoulder dystocia promptly and effectively to minimize these risks.

Hyperemesis gravidarum causes significant electrolyte disturbances, leading to hyponatraemia, hypokalaemia, hypochloraemia, and metabolic alkalosis. This is due to the severe nausea, vomiting, and weight loss experienced during pregnancy. While metabolic acidosis may occur in rare cases, it is not typically associated with hyperemesis gravidarum, as blood tests do not indicate elevated ketone levels. A mixed respiratory and metabolic acidosis is also not expected in these patients, as it is more commonly seen in those with COPD.

Hyperemesis gravidarum is a severe form of nausea and vomiting that affects around 1% of pregnancies. It is usually experienced between 8 and 12 weeks of pregnancy but can persist up to 20 weeks. The condition is thought to be related to raised beta hCG levels and is more common in women who are obese, nulliparous, or have multiple pregnancies, trophoblastic disease, or hyperthyroidism. Smoking is associated with a decreased incidence of hyperemesis.

The Royal College of Obstetricians and Gynaecologists recommend that a woman must have a 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance before a diagnosis of hyperemesis gravidarum can be made. Validated scoring systems such as the Pregnancy-Unique Quantification of Emesis (PUQE) score can be used to classify the severity of NVP.

Management of hyperemesis gravidarum involves using antihistamines as a first-line treatment, with oral cyclizine or oral promethazine being recommended by Clinical Knowledge Summaries. Oral prochlorperazine is an alternative, while ondansetron and metoclopramide may be used as second-line treatments. Ginger and P6 (wrist) acupressure can be tried, but there is little evidence of benefit. Admission may be needed for IV hydration.

Complications of hyperemesis gravidarum can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth restriction, pre-term birth, and cleft lip/palate (if ondansetron is used during the first trimester). The NICE Clinical Knowledge Summaries recommend considering admission if a woman is unable to keep down liquids or oral antiemetics, has ketonuria and/or weight loss (greater than 5% of body weight), or has a confirmed or suspected comorbidity that may be adversely affected by nausea and vomiting.